Your browser doesn't support javascript.
loading
ARL5b inhibits human rhinovirus 16 propagation and impairs macrophage-mediated bacterial clearance.
Faure-Dupuy, Suzanne; Jubrail, Jamil; Depierre, Manon; Africano-Gomez, Kshanti; Öberg, Lisa; Israelsson, Elisabeth; Thörn, Kristofer; Delevoye, Cédric; Castellano, Flavia; Herit, Floriane; Guilbert, Thomas; Russell, David G; Mayer, Gaell; Cunoosamy, Danen M; Kurian, Nisha; Niedergang, Florence.
Afiliação
  • Faure-Dupuy S; Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, 75014, France.
  • Jubrail J; Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, 75014, France.
  • Depierre M; Southampton Solent University, East Park Terrace, Southampton, SO14 0YN, UK.
  • Africano-Gomez K; Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, 75014, France.
  • Öberg L; Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, 75014, France.
  • Israelsson E; Translational Science & Experimental Medicine, Research & Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, 413 14, Sweden.
  • Thörn K; Translational Science & Experimental Medicine, Research & Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, 413 14, Sweden.
  • Delevoye C; Translational Science & Experimental Medicine, Research & Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, 413 14, Sweden.
  • Castellano F; Institut Curie, Université PSL, CNRS, UMR144, Structure and Membrane Compartments, Paris, France.
  • Herit F; Institut Curie, Université PSL, CNRS, UMR144, Cell and Tissue Imaging Facility (PICT-IBiSA), Paris, France.
  • Guilbert T; Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, 75014, France.
  • Russell DG; Université Paris Est Creteil, INSERM, IMRB, Creteil, 94010, France.
  • Mayer G; Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, 75014, France.
  • Cunoosamy DM; Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, 75014, France.
  • Kurian N; Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853, USA.
  • Niedergang F; Immunology, Late stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, 413 14, Sweden.
EMBO Rep ; 25(3): 1156-1175, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38332148
ABSTRACT
Human rhinovirus is the most frequently isolated virus during severe exacerbations of chronic respiratory diseases, like chronic obstructive pulmonary disease. In this disease, alveolar macrophages display significantly diminished phagocytic functions that could be associated with bacterial superinfections. However, how human rhinovirus affects the functions of macrophages is largely unknown. Macrophages treated with HRV16 demonstrate deficient bacteria-killing activity, impaired phagolysosome biogenesis, and altered intracellular compartments. Using RNA sequencing, we identify the small GTPase ARL5b to be upregulated by the virus in primary human macrophages. Importantly, depletion of ARL5b rescues bacterial clearance and localization of endosomal markers in macrophages upon HRV16 exposure. In permissive cells, depletion of ARL5b increases the secretion of HRV16 virions. Thus, we identify ARL5b as a novel regulator of intracellular trafficking dynamics and phagolysosomal biogenesis in macrophages and as a restriction factor of HRV16 in permissive cells.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rhinovirus / Macrófagos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: EMBO Rep Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rhinovirus / Macrófagos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: EMBO Rep Ano de publicação: 2024 Tipo de documento: Article